Abstract. The aim of this study was to investigate the function of microRNA (miR)-193-3p in human intrahepatic cholangiocarcinoma (ICC) tissues and cells. To evaluate whether miR-193-3p was aberrantly upregulated, we used reverse transcription-quantitative polymerase chain reaction to detect the level of miR-193-3p in ICC tissues and ICC-9810 cells. The effects of miR-193-3p downregulation on ICC cell proliferation, migration and invasion were also measured by MTT, wound-healing and Transwell assays. Additionally, transforming growth factor-β receptor type 3 (TGFBR3) was investigated as a direct target of miR-193-3p by dual-luciferase reporter assays and western blot analyses. The results demonstrated that miR-193-3p was aberrantly upregulated in ICC tissues and cell lines. Furthermore, TGFBR3 was confirmed to be a target of miR-193-3p in ICC and was notably upregulated by miR-193-3p knockdown in the ICC-9810 cells. The knockdown of miR-193-3p also exerted direct inhibitory effects on the proliferation, migration and invasion of the ICC-9810 cells. Therefore, we present evidence that miR-193-3p plays a key role in promoting human ICC by regulating TGFBR3.
Introduction
Intrahepatic cholangiocarcinoma (ICC) represents the second most common primary hepatic malignancy, accounting for 5-10% of liver cancers (1) . The incidence rate of ICC is relatively low in most populations, including those of the the USA and Europe, although is considerably higher in China.
M i c r o R N A s ( m i R N A / m i R s), a c l a s s o f non-protein-coding RNAs, are short ribonucleic acid molecules of approximately 17-25 nucleotides in length that typically bind to the 3' untranslated regions (3'UTRs) of target mRNAs to regulate their expression levels (2) . miRNA are important regulators of gene expression, and the expression levels of miRNAs have been closely associated with cell growth, proliferation, and development, as well as the occurrence and progression of several diseases (3) . miRNAs also regulate cell apoptosis, migration, invasion, proliferation, and tumorigenesis by regulating target genes (4) . Human miR-193-3p has been demonstrated to be upregulated in ICC cells; however, the detailed functional mechanisms of miR-193-3p in ICC remain unclear.
The transforming growth factor-β (TGF-β) receptor type 3 (TGFBR3) serves as an important tumor-suppressive factor in many cancer types. For instance, TGFBR3 has been reported to suppresse breast cancer progression by inhibiting cell migration and invasion, as well as angiogenesis. Additionally, loss or reduced levels of TGFBR3 expression have been identified in many types of human cancer, including non-small cell lung cancer (NSCLC), ovarian, prostate, pancreatic, breast and renal cell carcinoma, and overexpression of TGFBR3 can lead to inhibited cancer cell migration and invasion. Therefore, it has been conclusded that TGFBR3 might play a suppressive role in the progression of several cancers (5) (6) (7) (8) (9) (10) . However, Gatza et al (11) reported that TGFBR3 was markedly upregulated in human colon cancer and may advance the development of colon cancer to a certain degree. These findings indicated that TGFBR3 might play a dual role in the formation of tumors.
TGFBR3 is an accessory receptor that binds and modulates the activity of TGF-β, and these two members of the TGF-β growth factor superfamily regulate many of the functions in reproductive biology (12) . Furthermore, a recent study showed that downregulation of TGF-β signaling in cholangiocytes promoted cholangiocarcinoma by increasing cholangiocyte proliferation, which suggests the role of TGF-β signaling in cholangiocarcinoma (13) .
In the present study, we explored the expression of miR-193-3p in human ICC tissues and cells and determined whether downregulation of miR-193-3p could exert inhibitory effects on ICC cell proliferation, migration, and invasion. In addition, miR-193-3p was upregulated to investigate its direct effect on TGFBR3 levels in ICC. Thus, this study aimed to investigate the roles of miR-193-3p in ICC, and to verify whether TGFBR3 is a downstream target gene of miR-193-3p in ICC. 
Materials and methods

ICC
RNA isolation and reverse transcription-quantitative polymerase chain reaction (RT-qPCR).
Total RNA was isolated from the tissue samples and cell lines with an RNeasy mini kit (Invitrogen; Thermo Fisher Scientific, Inc.) following the manufacturer's instructions, and cDNA synthesis was performed with a reverse transcription kit (Promega Corporation, Madison, WI, USA). The mRNA expression levels of miR-193-3p, TGFBR3, TGF-β and GAPDH (internal control) were determined with a Power SYBR-Green Real-Time PCR Master Mix Kit (Takara Bio, Inc., Otsu, Japan). The following primers were used for PCR: For miR-193-3p, 5'-AAC TGG CCT ACA AAG TCC CAGT-3'; for TGFBR3 forward, 5'-CCT TCC GTT TCC TTT CCC AGA-3' and reverse, 5'-CAC ATT TGA CAG ACA GGG CAAT-3' (product size, 170 bp); for TGF-β forward, 5'-CAA TTC CTG GCG ATA CCT CAG-3' and reverse, 5'-GCA CAA CTC CGG TGA CAT CAA-3' (product size, 86 bp); GAPDH forward, 5'-ACA ACT TTG GTA TCG TGG AAGG-3' and reverse, 5'-GCC ATC ACG CCA CAG TTTC-3' (product size, 101 bp). All RT-qPCR reactions were performed in a BIO-RAD CFX96™ system (Bio-Rad Laboratories, Inc., Hercules, CA, USA). The relative expression levels were quantified using the 2 -ΔΔCq method (15) . All RT-qPCR reactions were repeated three times. ) was added to each experimental well, after which the plates were returned to the incubator and maintainedat 37˚C in a humidified atmosphere of 5% CO 2 for 4 h. Following aspiration of the supernatant, 200 µl dimethyl sulfoxide (Sigma-Aldrich; Merck KGaA, Darmstadt, Germany) was added to each well to dissolve the formazan crystals. Cell viability was subsequently analyzed at a wavelength of 570 nm using a micro plate reader.
Dual-luciferase reporter gene assay. For the luciferase assays, a pGL3 firefly luciferase reporter gene vector (30 ng/Ml; Promega Corporation) with the 3'UTR-WT or 3'UTR-MUT fragment of human TGFBR3 Cdna, containing the putative target site for miR-193-3p, was co-transfected with 50 nM miR-193-3p or miR-NC into ICC-9810 cells. A Renilla luciferase construct was also co-transfected to normalize the transfection efficiency. After 24 h, a Dual-Luciferase Reporter Assay System (Promega Corporation) was used to detect the relative luciferase activities, according to the manufacturer's instructions, under a FL500 microplate fluorescence reader (Omega Bio-Tek, Inc., Norcross, GA, USA). More than three independent experiments were performed.
Wound-healing migration assay. The migratory ability of ICC-9810 cells was measured with a Wound healing assay. The ICC-9810 cells were plated into 6-well plates (25,000 cells/well) with 2 ml of cell suspension in each well. When cell confluence reached 80%, a sterile Eppendorf pipette tip was used to scratch the cell surface to create a wound area. Following removal of the debris, the culture was replenished with fresh medium and incubated under 5% CO 2 at 37˚C for 24 h. The migration of the ICC-9810 cells into the wound area was detected under phase contrast objectives (x10) on a CK2 inverted microscope (DM16000; Leica Microsystems GmbH, Wetzlar, Germany) (16).
Transwell assay. The invasion of ICC-9810 cells was measured using a Transwell assay. The upper membrane surface was coated with Matrigel (BD Biosciences, Franklin Lakes, NJ, USA) and 500 µl RPMI-1640 medium containing 10% FBS was added into the lower chambers. Serum-free DMEM and ICC-9810 cell suspension (1x10 5 cells) were placed in the upper chambers. After culturing for 48 h, 4% paraformaldehyde and 0.05% crystal violet were used to fix and stain the invaded cells, respectively, and a cotton swab was used to remove the non-invaded cells in the upper chamber. A microscope (x100) was subsequently used to count the numbers of cells in 10 random fields in order to estimate the relative invasiveness of cells in the different groups (16) .
Western blot assay. The relative protein expression levels of TGFBR3 and TGF-β in the tissue samples and cell lines were detected by western blotting. The total protein content of the tissues and cells was harvested using radio-immunoprecipitation assay buffer (RIPA Buffer; BioVision, Inc., Milpitas, CA, USA), and protein concentration was determined by the BCA method. Subsequently, total protein (40 µg/sample) was separated by 10% SDS-PAGE and transferred to polyvinylidene difluoride membranes (Thermo Fisher Scientific, Inc.). The membranes were blocked with 10% nonfat milk in Tris-buffered saline with Tween (TBST; Invitrogen; Thermo Fisher Scientific, Inc.) for 2 h at room temperature, and then incubated with primary antibodies against TGFBR3 (ab78421), TGF-β (ab220084) and GAPDH (ab8245; all from Abcam Cambridge, UK) overnight at 4˚C. Subsenquently, the membranes were washed with TBST and incubated with horseradish peroxidase-coujugated secondary antibodies for 2 h at room temperature. The blots were visualized using an enhanced chemiluminescence film kit (New England Nuclear, Boston, MA, USA) according to the manufacturer's instructions, and Image J software was used to analyse protein density.
Statistical analysis. All data were expressed as the mean ± standard deviation of at least three independent experiments. All statistical analyses was performed using SPSS version 19.0 statistical software (SPSS, Inc., Chicago, IL, USA) and GraphPad Prism 6.0 software (GraphPad Software, Inc., La Jolla, CA, USA). A Student's t-test was used to evaluate the statistical significance of difference between two groups, whiledifferences between multiple groups were assessed by one-way analysis of variance followed by the Dunnett's post hoc test. P<0.05 was considered to indicate a statistically significant difference.
Results
Expression of miR-193-3p, TGFBR3 and TGF-β in the tissues of ICC patients.
On RT-qPCR and western blot analysis, the expression levels of miR-193-3p and TGFBR3 were found to be increased in tumor tissue samples of ICC patients when compared with adjacent normal tissues (P<0.01; Fig. 1 ). By contrast, TGF-β was significantly downregulated in the ICC tissues of the patients (P<0.01; Fig. 1 ). 
miR-193-3p expression is upregulated in the ICC
Expression of TGFBR3 and TGF-β in the ICC-9810 cell line.
The mRNA and protein levels of TGFBR3 and TGF-β in the ICC-9810 cells were detected by RT-qPCR and western blot analysis. The results indicated that the mRNA and protein levels of TGFBR3 in the miR-193-3p inhibitor group were significantly increased compared with those in the NC and miR-193-3p inhibitor control groups (P<0.01; Fig. 3A and B) . Conversely, we found that the mRNA and protein expression levels of TGF-β in the miR-193-3p inhibitor group were lower than that in the NC and miR-193-3p inhibitor control groups (P<0.01; Fig. 3A and B) . 
ICC-9810 cell proliferation was repressed following
Validation of TGFBR3 as a direct target of miR-193-3p.
A dual-luciferase reporter gene assay was used to test the binding relationship between miR-193-3p and TGFBR3. The complimentary sequences for miR-193-3p in the 3'UTR of TGFBR3 were obtained from the TargetScan database (Fig. 4B) . Cells co-transfected with miR-193-3p and the TGFBR3 3'UTR-WT exhibited lower intracellular luciferase activity than those transfected TGFBR3 3'UTR-WT alone (P<0.05; Fig. 4B) . Meanwhile, the luciferase activity of cells co-transfection with miR-193-3p and mutant TGFBR3 3'UTR-MUT did not differ from that of the NC + TGFBR3 3'UTR-MUT or the control + TGFBR3 3'UTR-MUT groups. This date indicated that TGFBR3 was negatively regulated by miR-193-3p, consistently with the western blotting results, which indicated that the inhibition of miR-193-3p could increase the expression of TGFBR3 (Fig. 2A) . Thus, we concluded that miR-193-3p could directly target TGFBR3 and inhibit its expression at the mRNA and protein levels. 
miR-193-3p downregulation or TGFBR3 overexpression suppresses the migration and invasion ability of ICC-9810 cells.
The migratory ability of ICC-9810 cells was measured using a wound healing assay. The results showed that the migration distance of ICC-9810 cells in the miR-193-3p inhibitor group was markedly lower than that NC and miR-193-3p inhibitor control groups (P<0.01; Fig. 5A and C) . Similarly, to investigate the invasive ability of ICC-9810 cells, we measured the numbers of invaded in a Transwell assay. In the microscope images (magnification, x200), significantly fewer invaded cells were observed in the miR-193-3p inhibitor group than in the NC and miR-193-3p inhibitor control groups (P<0.01; Fig. 5B and D) . In summary, these results indicated that the downregulation of miR-193-3p leading to TGFBR3 overexpression could inhibit the invasion and migration of ICC-9810 cells.
Discussion
ICC is a common primary liver tumor with increasing incidence worldwide. The clinical outcomes of ICC are typically worse than those for hepatocellular carcinoma due to its non-specific presentation and detection at more advanced stages (17) . A previous study suggested that miR-193-3p predominantly exerted an oncogenic effect in gastric cancer (18) ; however, interestingly, in human NSCLC, miR-193-3p was downregulated in the cancer cells, indicating that miR-193-3p may act as a tumor suppressor to inhibit the proliferation and migration of NSCLC (19) . Similarly, a previous miRNA analysis demonstrated that miR-193-3p was significantly downregulated in the lung tissue and serum of PAH patients (4). In the current study, which aimed to explore the functional significance of miR-193-3p in ICC, we demonstrated by RT-qPCR that miR-193-3p was upregulated in ICC-9810 cells when compared with HIBECs, and in ICC tissues compared with adjacent normal tissues. Further data showed that miR-193-3p enhanced the proliferation, invasion and migration of ICC-9810 cells. Collectively these findings indicated that miR-193-3p may act as an oncogene in ICC. Considering the multiple functions of miR-193-3p within complex signaling pathways during the development of different cancers, we conclude that miR-193-3p may act as either an oncogene or a tumor suppressor gene depending on the cancer type.
Previous research has shown that TGFBR3 may play a dichotomous role in human bladder cancer, acting as both a tumor suppressor and tumor promoter (20) . Based on these findings, we speculated that there may be a potential relationship between TGFBR3 and miR-193-3p in ICC, and found that TGFBR3 was a direct target gene of miR-193-3p in ICC. Our studies also showed that TGFBR3 expression was upregulated by miR-193-3p downregulation in ICC, thus indicating that TGFBR3 is not only a tumor suppressor, but is also directly regulated by miRNA in ICC.
In conclusion, the downregulation of miR-193-3p directly affected TGFBR3 expression and suppressed the proliferation, migration and invasion of ICC cells. Therefore, our study provides that miR-193-3p may promote the invasion and migration of ICC cells by directly targeting TGFBR3 and reducing its expression.
To the best of our knowledge, this study is the first to elucidate mechanistic functions of miR-193-3pregarding its role in human ICC. Notably, we identified that TGFBR3 was closely related to the regulatory effects of miR-193-3p in ICC. These findings may provide a basis for therapeutic strategies in the treatment of ICC.
